KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Invested Capital (2018 - 2025)

Historic Invested Capital for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $796.1 million.

  • Vir Biotechnology's Invested Capital fell 3583.62% to $796.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $796.1 million, marking a year-over-year decrease of 3583.62%. This contributed to the annual value of $1.2 billion for FY2024, which is 2664.96% down from last year.
  • Latest data reveals that Vir Biotechnology reported Invested Capital of $796.1 million as of Q3 2025, which was down 3583.62% from $947.5 million recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Invested Capital ranged from a high of $2.1 billion in Q3 2022 and a low of $675.4 million during Q1 2021
  • Over the past 5 years, Vir Biotechnology's median Invested Capital value was $1.4 billion (recorded in 2024), while the average stood at $1.4 billion.
  • In the last 5 years, Vir Biotechnology's Invested Capital skyrocketed by 19629.24% in 2022 and then crashed by 3583.62% in 2025.
  • Quarter analysis of 5 years shows Vir Biotechnology's Invested Capital stood at $1.4 billion in 2021, then soared by 45.12% to $2.1 billion in 2022, then dropped by 23.47% to $1.6 billion in 2023, then fell by 26.65% to $1.2 billion in 2024, then tumbled by 31.75% to $796.1 million in 2025.
  • Its last three reported values are $796.1 million in Q3 2025, $947.5 million for Q2 2025, and $1.1 billion during Q1 2025.